Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Forums Movies Games
Sign In Sign Up
Night Mode
Infectious-Disease and Endocrine Testing Drive CLIA Adoption
Chemiluminescence immunoassay technology is becoming an essential part of clinical testing because it can detect low concentrations of biomarkers with speed and accuracy. Its use in infectious-disease and endocrine testing is creating strong demand for analyzers, kits, and reagents. The Chemiluminescence Immunoassay Market is projected to grow from USD 6.56 billion in 2024 to USD 11.22 billion...
0 Comments ·0 Shares ·188 Views ·0 Reviews
Please log in to like, share and comment!